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A retrospective study was conducted, including61 patients with long-term intravasculardevices (IVDs) admitted to the Childrens
HospitalLosAngeleswithdiverseunderlyingdiseases,diﬀerenttypesofcatheters,andculture-proven catheter-related bloodstream
infections(BSIs).Withinthesepatients,125catheter-related BSIsoccurred, andtheincidenceofmonomicrobialandpolymicrobial
BSIs was evaluated. Risk factors for polymicrobial BSIs were determined. Forty-two BSIs contained more than one pathogen.
These polymicrobial BSIs were observed more often in younger patients (<4.1 years versus ≥4.1 years) and less in patients using
venousimplantedports. No otherassociationswere foundbetween theoccurrences of polymicrobialBSIsandunderlying diseases,
other types of catheters, host defense status, parenteral nutrition, recurrences, or catheter removal. Patients with long-term IVDs
at a younger age have a higher risk of developing a polymicrobial BSI. Future prospective studies should address the issue of
polymicrobial infection in IVDs in more detail.
1.Introduction
Intravascular devices (IVDs) are a crucial tool in the treat-
ment of pediatric patients with diverse underlying diseases.
Theyprovideareliableaccesssiteforfrequenttransfusions of
bloodproducts,prolongedintravenousmedications,chemo-
therapy, apheresis, parenteral nutrition, and blood sampling.
However, catheter-related bloodstream infections (BSIs)
have emerged as the most important cause of infections in
children with intravascular devices (IVDs) [1]. More than
80% of primary bacteriaemia are considered to be catheter
associated in the adult population [2].
The incidence of individual monomicrobial pathogens
in BSIs have been studied identifying diﬀerent risk factors,
such as age, underlying disease, type of catheter, and
immune status [3–6]. However, epidemiological data about
the incidence and risk factors of catheter-related BSIs caused
by polymicrobial infections are scarce [7]. Two reports in the
1980s and one study most recently describe polymicrobial
bacteriaemia in children [8–10], identifying predisposing
factors as underlying disease, types of IVD, and immune
status. Age of the patients as a risk factor was not included.
Recently, catheter-related BSIs were investigated in pediatric
patients in ambulatory care, showing that younger children
were at a greater risk of obtaining a polymicrobial infection
than older children [11]. Since studies in adults have shown
that polymicrobial infections are related to higher risks of
mortality and morbidity, this association could be of clinical
importance [12, 13].
Recently, we have reported a retrospective study on the
use of the ethanol-lock technique for the treatment of cath-
eter-related BSIs [14]. In a secondary analysis of this study,
we evaluated the frequency of monomicrobial and polymi-
crobial BSIsin this case series of pediatric patients, and iden-
tiﬁed the clinical risk factors associated with the occurrence
of polymicrobial infections in an inpatient setting.2 Journal of Pathogens
2.MaterialandMethods
2.1. Study Design. Since the primary purpose of the original
studywas toevaluatetheeﬀectoftheethanol-locktechnique,
patients with catheter-related BSIs in need for the ethanol-
lock technique were identiﬁed in retrospect by assessing the
pharmacy dispensing records. All patients with IVDs treated
with ethanol-locks from the 1st of June 2004 through
the 22nd of June 2005 were included [14]. Patients were
eligible for ethanol-lock treatment if they had persistent
positive blood cultures (persistent positive blood cultures
after 48-hours’ administration of appropriate intravenous
antimicrobial therapy), or incidence of multiple catheter-
related BSIs. The patient also had to be older than 6 months
of age, a patent lumen, and a negative history of allergy to
alcohol. These eligible patients were identiﬁed after appro-
priate approval from the CHLA Institutional Review Board.
Patients who received ethanol-locks for any other purpose
than a catheter-related BSI were excluded.
Data of all BSIs occurring in the included IVDs were
extracted by chart review from the beginning of the study
(or the ﬁrst day of insertion) until the end of the study
period, regardless whether the BSIs occurring in that IVD
were treated with ethanol-locks. For example, if an IVD was
treated with ethanol-lock therapy only during a ﬁrst BSI but
not on the consecutiveoccasions, thedata on the consecutive
BSIs in that same IVD during the study period were also
included.
2.2. Data Extraction and Study Deﬁnition. Catheter-related
BSIs were deﬁned as clinical suspicion of infection (fever,
chills, unexplained leukocytosis, hypotension, and/or tachy-
cardia) with no clear focus apart from the IVD, or signs
of local infection around the insertion site, in combination
with a positive blood culture from a catheter segment. No
concomitant peripheral blood cultures were obtained.
The collected data included the number of BSIs within
the same IVD, the presence of polymicrobial or monomicro-
bialBSIs,thediﬀerentpathogenscausing thecatheter-related
BSI, recurrence, and removal of the IVD as a direct result
of an infection. The clinical information that was extracted
included: age, gender, underlying disease, type of catheter,
the use of parenteral nutrition, and the presence or absence
of neutropenia.
A polymicrobial BSI was deﬁned as the isolation of more
than one pathogen from the same blood sample or from
two consecutive samples within 24 hours. We chose the
calculated median age of our case series, as a more objective
measurement to divide the patients into a younger and older
age group. Patients with diverse underlying diagnoses were
divided into four categories, because of the diﬀerences in
treatment regimens, product exposure and interventions.
The ﬁrst category included oncology patients exposed to
chemotherapy, the second consisted transplanted patients
because of the intensity of the chemotherapy and the third
g r o u pi n c l u d e dp a t i e n t sw i t hg astrointestinal disorders on
long-term parenteral nutrition. The 4th group was deﬁned
asnonimmunosuppressed patientswith intermittentmanip-
ulationofthe catheterand a relative short dwelling time. The
types of catheters were divided according to their number
of lumina. A Broviac is a single-lumen catheter, whereas
a Hickmann and Med-comp are double-lumen catheters.
Although a venous implanted port is a single-lumen IVD,
this device was categorized separately, because it is totally
implanted. The PICC (peripherally inserted central catheter)
was analyzed separately as well, becausethis is a nontunneled
single-lumen IVD. Neutropenia was deﬁned as an absolute
granulocyte count below 500cells/mm3. The usage of long-
term parenteral nutrition was deﬁned as dependency on
parenteralnutritionformorethan28consecutivedaysinone
IVD [10]. Since there is no deﬁnition available in literature,
we deﬁned arecurrent BSIashaving anothercatheter-related
BSI within 30 days of the previous one with the same
pathogen.
To explore the possible bias of analyzing polymicrobial
versus monomicrobial BSIs in IVDs with multiple consecu-
tive BSIs, where the next BSIs might not be independent of
the previous one, a subgroup of only the ﬁrst BSIs in every
IVDwasanalyzed. Theusageofethanol-locksandantibiotics
in the previous BSI might also inﬂuence the results. Since
neither of the primary BSIs in every catheter was treated
with this technique or antibiotics, this created subgroup
also explored the possible bias of using ethanol-locks and
antibiotics.
2.3. Statistical Analysis. Comparison of the frequency distri-
bution of polymicrobial BSIs in relation to the diﬀerent risk
factors and outcome were calculated in univariate analyses
using odds ratios with 95% conﬁdence intervals (CI) and
corresponding P values. Multivariate logistic regression
models were used to ﬁnd the determinants independently
associated with polymicrobial BSIs in catheter-related infec-
tions. All statistical tests were two-sided and considered sig-
niﬁcant when P<. 05. All data were analyzed using Inter-
cooled Stata 9.2 (Stata Corporation, College Station, TX,
USA).
3.Results
In the study period, the pharmacy dispensed ethanol-lock
treatments to 79 IVDs in 75 patients. Eleven patients were
excluded because the prescribed treatment was for a reason
other than infection, such as mechanical problems with the
line (n = 8), prophylaxis (n = 2) or fever of viral origin (n =
1). Three patients were excluded due to insuﬃcient data.
Compared to our original study fewer patients and BSIs were
excluded from the analyses, since the eﬃcacy of the ethanol-
locks was not the issue in the present study. Therefore,
those patients and events with incomplete indwelling time
or period of the ethanol-locks, still on ethanol therapy at the
endofthestudy periodandthepatientswith aPICCinserted
could be included in this study [14].
The patients’ characteristics are shown in Table 1.F o u r
patients received a second IVD during the study period.
Sixty-one patients had 125 BSIs during the study period.
Median age of the cohort was 4.1 years. There were 4
diagnostic groups; the oncology group consisted of patientsJournal of Pathogens 3
Table 1: Patient characteristics.
Median (IQRa)
Age patients in years 4.1 (1.9–12.5)
Total number (%)







Broviac single-lumen 13 (20)
Hickman/Med-comp double-lumen 32 (49.2)
Venous implanted port 11 (16.9)
PICCc 9 (13.9)
Number of BSIsd
1 BSI 30 (49.2)
2 BSIs 15 (24.6)
3 BSIs 10 (16.4)
4B S I s 4( 6 . 6 )
6B S I s 1( 1 . 6 )
13 BSIs 1 (1.6)
aIQR: interquartile range; bPICC: peripherally inserted central catheter;
cincluding benign hematological diagnosis, metabolic disorders, cardiac
issues, and a patient with VACTERL; dBSI: catheter-related bloodstream
infection.
with solid tumors or hematological malignancies, the trans-
plant group consisted of patients who were having bone
marrow transplantations, as well as recipients oforgan trans-
plantation. The gastrointestinal group had patients with
short bowel syndrome, pseudo-obstruction syndrome or
microvillous inclusion syndrome. The 4th category was
a diverse group of patients with benign hematological diag-
noses, metabolic disorders, cardiac issues and a patient with
VACTERL (vertebral anomalies, anal atresia, cardiac malfor-
mations, tracheoesophageal ﬁstula, renal anomalies, and
limb anomalies).
Table 2 lists the pathogens found in the 125 BSIs con-
taining monomicrobial and polymicrobial infections. A total
of 186 pathogens were cultured in 42 polymicrobial and
83 monomicrobial BSIs. The polymicrobial BSIs contained
relatively more enterococci(n = 21).Seventy-fourpercentof
the polymicrobial BSIscontained one or more gram-positive
bacilli, 57.1% of the BSIs contained one or more gram-
negativeBSIsand11.9%oneormoreyeast.Themonomicro-
bial BSIs were predominantly Gram-positive BSIs (72.3%).
Results of the univariate analysis of risk factors for
a polymicrobial BSIare shown inTable 3.Polymicrobial BSIs
were found in 74% of BSIs from children <4.1 years of age
compared to only 26% of BSIs from the older age group,
with a statistically signiﬁcant odds ratio. No association was
seen between the frequency of polymicrobial BSIs and the
diﬀerent categories of diagnosis or the types of catheter,
except for venous implanted ports. Less polymicrobial BSIs
were seen in the venous implanted port with a statistical
signiﬁcant odds ratio. Additional analyses combining the
PICCs and all single-lumen central catheters, including
the venous implanted ports as one group did not reveal
a signiﬁcant association (odds ratio 0.84; 95% conﬁdence
interval 0.40, 1.78; P = .66). Neither neutropenia nor the
usage of long-term parenteral nutrition was associated with
a higherrisk for polymicrobial BSIs. PolymicrobialBSIswere
not associated with a higher risk of recurrence or requiring
removal of the aﬀected IVD.
Analysis of the subgroup including only the ﬁrst BSI in
every IVD, revealed that the age group <4.1 years had 15
polymicrobial BSIs (48.4%) and 16 monomicrobial BSIs
(51.6%) compared to 8 polymicrobial BSIs (26.7%) and 22
monomicrobial BSIs (73.3%) in those ≥4.1 years. There was
a nonsigniﬁcant trend towards an association between the 2
age groups (odds ratio 0.33; 95% conﬁdence interval 0.13,
1.13; P = .08).
Themultivariate model,includingallpredeﬁnedrisk fac-
tors, failed due to collinearity and small numbers. However,
potential confounders for the association between polymi-
crobial BSIs and younger age were explored by performing
multivariate analyses including one confounder at the time
in the model. None of the potential confounders investigated
alteredtherelation between ageand therisk ofpolymicrobial
BSIs (Table 4).
4.Discussion
In our retrospective study, we found comparable numbers
of various bacteria as reported by others [11, 15, 16], but
also a considerableamount ofpolymicrobial BSIsinchildren
with an IVD. A possible explanation for this amount of
polymicrobial BSIs could be that only patients treated with
ethanol-locks were included in this study. To be eligible for
this treatment the catheter-related BSI had to be persistent
or recurrent. As recently reported polymicrobial BSIs are
associated with prolonged bloodstream infections [10].
The analysis of this study on possible risk factors for
polymicrobial BSIs revealed a signiﬁcantly higher risk of
polymicrobial BSI occurrence in younger children. This pre-
dominance of polymicrobial BSIs in younger patients has,
most recently, been reported in children in an ambulatory
setting [11]. In line with this study, we conﬁrm this asso-
ciation in children in an inpatient setting. In addition to
this study, we have shown that other clinical factors, such
as diverse underlying diagnosis, immune status and the
use of parenteral nutrition revealed no such association.
The multivariate analysis suggested that the eﬀect of the
patient’s age on the risk of having polymicrobial BSIs was
not biased by any of the other clinical factors includedin this
study. This ﬁnding might have clinical consequences, since
mortalityandmorbidityishigherinpolymicrobialinfections
than in single gram-positive and gram-negative bacteriaemia
[12, 13, 17]. We found no relation between the occurrence of
polymicrobialBSIsandshort-termoutcomesasnecessitation
ofremovingtheIVDortherecurrenceofthesame pathogens
in that catheter. However, since this study was not designed
to evaluate the outcome of the occurrence of polymicrobial
BSIs, future larger studies should address this topic.4 Journal of Pathogens
Table 2: Monomicrobialand polymicrobial BSIs.
Pathogens MonomicrobialBSI (%) Polymicrobial BSI (%)a Total (%)
Gram-positive bacteria 60 (72.3) 53 (51.5) 113 (60.8)
a-hemolytic streptococci (viridans) 1 2
Streptococcus pneumoniae —1
Coagulase-negative staphylococci 42 21
Staphylococcus aureus 34
Methicillin-resistant Staphylococcus aureus 31
Enterococcus sp. 7 21
Bacillus sp. 4 3
Gram-negative bacteria 15 (18.1) 44 (42.7) 59 (31.7)
Enterobacter Klebsiella Serratia group 9 20
Escherichia coli 13
Pseudomonas sp. 1 8
Stenotrophomonas maltophilia 13
Actinobacter sp. 3 5
Other Gram negatives — 5
Yeast 8 (9.6) 6 (5.8) 14 (7.5)
Candida albicans 1—
Candida nonalbicans 76
Total 83 (100) 103 (100) 186 (100)
aTotal of 103 pathogens in 42 polymicrobial BSIs (33.6% of 125 BSIs).
Table 3: Associations between polymicrobial/monomicrobialBSIs and the diﬀerent risk factors and outcome.
MonomicrobialBSIsa (%) Polymicrobial BSIs (%) Odds ratio 95% CIb P value
Age
<4.1 40 (48.2) 31 (73.8) 1.0c
≥4.1 43 (51.8) 11 (26.2) 0.33 0.15–0.74 .007∗
Diagnosis
Oncology 34 (41.0) 21 (50.0) 1.0c
Transplantation 22 (26.5) 6 (14.3) 0.44 0.15–1.27 .13
Gastrointestinal 16 (19.3) 10 (23.8) 1.01 0.39–2.64 .98
Other 11 (13.2) 5 (11.9) 0.74 0.22–2.42 .61
Type of catheter
Single lumen 22 (26.5) 16 (38.1) 1.0c
Double lumen 38 (45.8) 21 (50.0) 0.76 0.33–1.75 .52
Venous implanted port 18 (21.7) 3 (7.1) 0.23 0.06–0.91 .038∗
PICCd 5 (6.0) 2 (4.8) 0.55 0.09–3.20 .51
Neutropenia
No 69 (83.1) 34 (81.0) 1.0c
Yes 14 (16.9) 8 (19.0) 1.16 0.44–3.03 .76
Parenteral nutrition
No 58 (69.9) 27 (64.3) 1.0c
Yes 25 (30.1) 15 (35.7) 1.29 0.59–2.83 .53
Recurrence
No 28 (80.0) 20 (76.9) 1.0c
Yes 7 (20.0) 6 (23.1) 1.20 0.35–4.11 .77
Removal
No 63 (75.9) 33 (78.6) 1.0c
Yes 20 (24.1) 9 (21.4) 0.86 0.35–2.10 .74
aBSIs: blood stream infections; b95% CI: 95% conﬁdence interval; creference group; dPICC: peripherally inserted central catheter; ∗statisticalsigniﬁcant.Journal of Pathogens 5
Table 4:Oddsratiosfortherelationbetween polymicrobialBSIand
age of patients adjusted for potential clinical confounders.
Potential confounder Adjusted ORa (95% CIb) P value
Diagnosis 0.29 (0.13, 0.68) .004
Type of catheter 0.39 (0.16, 0.95) .038
Neutropenia 0.33 (0.14, 0.74) .008
Parenteral nutrition 0.33 (0.14, 0.77) .009
Recurrence 0.25 (0.08, 0.82) .023
Removal 0.33 (0.14, 0.75) .008
aOR: odds ratio; b95% CI: 95% conﬁdence interval.
The second conclusion from this study was that venous
implanted ports have a lower risk of getting infected by
a polymicrobial BSI than partially implanted catheters.
Previous studies had already shown this, leading to a recom-
mendation of using ports, when feasible [18–20]. Our data
support that conclusion.
As described above, a subsequent new BSI in an IVD
might not be independent from the previous one in that
same catheter and may bias the results described above. Sec-
ond,theprimary choiceofantibioticsmight beaconfounder
of the reported results, although hospital policy prescribed
the same broad-spectrum antibiotics to all patients, regard-
less of age. Third, treatments with ethanol-locks might also
inﬂuence the occurrences of microorganisms in IVDs. We
investigated the possible bias of the used antibiotics and
ethanol-lock treatment by analyzing only the ﬁrst BSI of
every catheter. Of course, the ﬁrst infection in every catheter
did not have a previous BSI and were not yet treated with
the ethanol-locks. This analysis showed the same increased
risk of polymicrobial BSIs at a younger age with a higher
conﬁdence interval, due to lack of power. This suggested that
the inclusion of multiple BSIs of one IVD, and the treatment
ofsomeBSIswithethanol-locks,didnotbiastheresults, thus
supporting the analysis of the whole case series.
This study has several limitations. First, since this was
a secondary analysis on a previously reported study on
ethanol-locks, there might be a selection bias including
patients treated with ethanol-locks. However, we found the
same association as the solely written publication on this
topic designed to investigate this topic [11]. Together with
our analysis including only the ﬁrst BSI in every catheter, we
feel that the eﬀect of selection bias on the found association
is less likely.
Second, no concomitant, peripherally drawn blood cul-
tures were obtained as our standard of practice in order to
minimize venipunctures in these children with signiﬁcant
venous access diﬃculties. A distinction between a BSI and
contamination might be diﬃcult when skin microbiota is
isolated[21].Gram-positive organisms, especially coagulase-
negative staphylococci are judged more to be contaminants
than gram-negatives in polymicrobial BSIs in pediatric
patients [9]. In our case series, all patients had clinical
symptoms of bacteriaemia, and therefore had a high ap r i o r i
chance of having a true BSI. Furthermore, a low fre-
quency of coagulase-negative staphylococci was found in the
polymicrobial BSIs, compared to the monomicrobial BSIs.
Furthermore, to be eligible for the ethanol-lock treatment
and included in this secondary analysis the catheter-related
BSI had to be persistent or recurrent, which suggests that
these BSI are not likely to be contaminated.
A possible explanation for the association between poly-
microbial BSIs and age could be diﬀerent groups of under-
lying illnesses with diﬀerent treatments, immune status and
diﬀerent types of catheters. However, none of the other
variables, (with the exception of venous implanted ports)
showed a relation with the frequency of polymicrobial BSIs.
Furthermore, younger children are less aware of the vul-
nerability of their IVD, resulting in risky behavior. Younger
children also have diﬀerent skin microbiota with faecal
contamination, which might result in a higher risk of getting
infectedbyapolymicrobialBSIthanolderchildren[1].More
parameters are to be considered as a risk factor, like the
number of manipulations, the site of insertion of the IVDs
or the occurrence of chemotherapy-induced mucositis. The
numberofmanipulations representsthemostimportant risk
factor for the development of BSI [19]. However, these data
were not available in this retrospective study.
In conclusion, given the limitations of a retrospective
study, our results suggest that a higher risk of polymicrobial
BSIs is associated with younger age and lower with venous
implanted ports. Future prospective studies including all
infants with IVDs, not only those treated with ethanol-
locks should conﬁrm these ﬁndings and address the issue of
polymicrobial infections in IVDs in more detail in view of
the risk and diﬃculty of eradication of these pathogens as
well as the need to retain functional IVDs in this vulnerable
pediatric population.
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